Search results
Beacon secures $170m to advance ophthalmic gene therapies
Pharmaceutical Technology· 16 hours agoBeacon says this makes AGTC-501 unique from other treatment approaches since it addresses the...
Could groundbreaking CAR-T cancer therapy trigger more cancer?
The Hindu· 22 hours agoIn the last few decades, scientists have finally learned to harness the immune system to...
Colgate-Palmolive (India) Ltd Stock Price: Colgate-Palmoliv Share Price Today | India Infoline
India Infoline· 4 hours agoColgate-Palmoliv Share Price: Get the live NSE/BSE stock price of Colgate-Palmolive (India) Ltd with performance, market cap, financial report, and company profile at India Infoline.
Centre exploring multiple models to cover seniors in Ayushman Bharat scheme
Livemint· 8 hours agoThe move is in keeping with a promise made by the ruling NDA (national democratic alliance) in the...
Budget 2024: Pharma sector demands substantial R&D incentives, tax relief and strong IP framework
Financial Express· 4 hours agoBudget 2024: As Finance Minister Nirmala Sitharaman will table the Union Budget 2024 later this...
Best Astrologer in Delhi in 2024
Mid Day· 13 hours agoPradip Verma's exceptional knowledge, accurate predictions, and compassionate approach have made him the most famous and Best Astrologer In Delhi In...
Eli Lilly Alzheimer's drug approved by US FDA - ET HealthWorld | Pharma
The Economic Times· 22 hours agoFood and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making...
Sun Pharma.Inds. Summary: Latest Updates and Details | India Infoline
India Infoline· 2 hours agoSun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in ...
5 FDA decisions to watch in the third quarter
BioPharma Dive· 23 hours agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...
EMA approves Sanofi’s Dupixent for COPD treatment in adults
Pharmaceutical Technology· 22 hours agoThe safety profile of Dupixent in these studies aligned with its known safety data from other...
